FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS
Rhythmlink | March 20, 2023
Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses.
As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023.
“We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.”
This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship.
“Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.”
Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring.
Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services.
About Graham Partners
Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.
DIGITAL HEALTHCARE, HEALTHCARE ANALYTICS
PointClickCare | March 17, 2023
PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, today announced the acquisition of Patient Pattern. The combination of PointClickCare and Patient Pattern will further the companies' shared vision of enabling better care and outcomes for high-needs populations and provide care teams with the solutions they need to successfully operate at the top of their license.
The shift to value-based care continues to accelerate each year, especially as providers are increasingly taking on more risk. According to a recent McKinsey and Company study, the number of patients treated within the value-based care landscape could roughly double in the next five years. Institutional Special Needs Plans (I-SNPs), demonstrate the enormous potential of aligned value-based care models.
“Senior care providers need support as they navigate new models of care and ultimately take on more risk-bearing responsibilities, inclusive of technology that helps them deliver exceptional care, particularly to high-needs populations,” said Travis Palmquist, Senior Vice President and General Manager of Senior Care at PointClickCare. “As our customers continue to embrace value-based care and see the success of this model, we are excited to deploy Patient Pattern’s care management platform. Care models will continue to evolve, and this strategic investment is another example of our commitment to helping our customers thrive in this evolving market, specifically, the opportunity to succeed with this shift to risk.”
Since its inception, PointClickCare has invested in innovation across the care continuum to close gaps in healthcare delivery through its rich and expansive insights. PointClickCare and Patient Pattern’s combined offerings provide a mechanism to adopt and succeed in risk-bearing arrangements without having to use multiple fragmented solutions. Through this acquisition, PointClickCare will further enable providers to take a comprehensive approach to frailty, ultimately providing better overall care planning.
“Over the past ten years, we’ve worked hard to integrate a care management philosophy and capabilities directly into our EHR,” said Dr. Steven Buslovich, co-founder and Chief Executive Officer at Patient Pattern. “We’re thrilled to join forces with PointClickCare as we march toward our collective goal of helping clinicians better predict and document risk, close care gaps, and improve patient outcomes. The marriage of an integrated care management platform with population health data will prove to be a major differentiator for us.”
Goodwin Procter LLP served as legal advisor and PricewaterhouseCoopers LLP served as tax and accounting advisor to PointClickCare. Nemphos Braue LLC served as legal advisor to Patient Pattern. Terms of the transaction were not disclosed.
PointClickCare is a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey. More than 27,000 long‐term and post‐acute care providers, over 2,800 hospitals and 2,000 ambulatory clinics, every major U.S. health plan across the U.S, and over 75 state and government agencies use PointClickCare, enabling care collaboration and value‐based care delivery for millions across North America.
Sectra | March 16, 2023
Sectra, a global healthcare IT leader, informed on March 15, 2023, that it has renewed its contract with Dutch hospital Zuyderland for another ten years.
Sectra One Cloud, a cloud-based version of its enterprise imaging product, is included in the arrangement, offering Zuyderland a scalable, secure, and professionally managed service. With Sectra managing the infrastructure, healthcare practitioners can focus on delivering exceptional patient care.
Ralph Berendsen, Medical Physicist at Zuyderland Medical Center, stated, "Our current infrastructure needs to be replaced, giving us the perfect opportunity to move over to Sectra's cloud solution."
He added, "We've been a happy customer of Sectra for many years, so letting them take full responsibility for our IT operations was an easy choice. Moving to the cloud will reduce our IT burden, giving us the time to focus on our users."
(Source – Cision PR Newswire)
The radiology, nuclear medicine, and orthopedic departments of Zuyderland Medical Center are in Sittard-Geleen and Heerlen. The company, which has been using Sectra's solution since 2017, will be the first Dutch company to adopt Sectra One Cloud, developed in Microsoft Azure.
Peter Osinga, Managing Director, Sectra Benelux and DACH, remarked, "Many healthcare providers are currently facing challenges when it comes to high workloads and a lack of resources. In addition, secure communication and sharing of sensitive data has never been more important. As a result, we are seeing increasing interest in cloud services."
He added, "I'm happy that Zuyderland remains satisfied with us as their technology provider, and I am proud of being trusted to manage their IT infrastructure."
(Source – Cision PR Newswire)
This contract, which includes radiology, breast imaging, and orthopedics, was finalized in February 2023.
Sectra strives to promote a better and more secure society by assisting health systems worldwide in improving care efficiency and helping European authorities and defense forces preserve sensitive information. Founded in 1978, the company's headquarters are in Linköping (Sweden). With global distribution partners, it conducts direct sales in 19 countries.